Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Viridian Therapeutics Inc 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 USA

www.viridiantherapeutics.com Employees: 143 P: 617-272-4600 F: 617-272-4601

Sector:

Medical

Description:

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

Key Statistics

Overview:

Market Capitalization, $K 2,791,679
Enterprise Value, $K 2,901,559
Shares Outstanding, K 95,442
Float, K 93,934
% Float 98.42%
Short Interest, K 8,149
Short Float 8.54%
Days to Cover 5.20
Short Volume Ratio 0.56
% of Insider Shareholders 1.58%

Financials:

Annual Sales, $ 300 K
Annual Net Income, $ -269,950 K
Last Quarter Sales, $ 70,570 K
Last Quarter Net Income, $ -34,600 K
EBIT, $ -328,120 K
EBITDA, $ -343,240 K

Growth:

1-Year Return 58.02%
3-Year Return -11.95%
5-Year Return 54.03%
5-Year Revenue Growth -93.27%
5-Year Earnings Growth 84.72%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 11/05/25
Next Earnings Date 02/26/26 [--]
Earnings Per Share ttm -3.02
EPS Growth vs. Prev Qtr 66.00%
EPS Growth vs. Prev Year 70.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 11/13/20

VRDN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -78.50%
Return-on-Assets % -47.13%
Profit Margin % -89,983.33%
Debt/Equity 0.04
Price/Sales 33.56
Price/Cash Flow N/A
Price/Book 7.58
Book Value/Share 6.16
Interest Coverage -87.51
60-Month Beta 0.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar